Ferreira P, Fonseca C, Morais H, Carvalho A, Ceia F, Luís A S
Serviço de Medicina/UCIM, Hospital S. Francisco Xavier.
Rev Port Cardiol. 1993 Nov;12(11):919-30, 900.
Heart failure (HF) is a dynamic clinical syndrome depending on multiple hemodynamic and neurohormonal factors. This syndrome concerns not only left ventricular systolic dysfunction but also left ventricular diastolic dysfunction and right ventricular dysfunction. Clinical features and therapeutic approaches are different for each of them. NYHA class IV is just one of the various prognostic factors of heart failure; consequently, severe heart failure is not synonymous of NYHA class IV.
To study hospitalised patients with heart failure in NYHA class IV, in order to characterise the predominant dysfunction, and analyze evolution and mortality.
A retrospective analysis of a prospective study.
Hundred and eight hospitalised patients (1985-89). Patients with chronic obstructive pulmonary disease and acute myocardial infarction were excluded.
Sixty nine patients: 29 female and 40 male, aged 18 to 81 years old (m = 59 +/- 15.5).
Patients were clinically examined and had chest radiographs, electrocardiogram and M + 2D mode echocardiogram. Three groups were identified: Group I-patients with predominant left ventricular systolic dysfunction; Group II-patients with predominant left ventricular diastolic dysfunction; Group III-patients with predominant right ventricular dysfunction.
41% of the patients had coronary artery disease; 44%, valvular heart disease; 11.8% dilated cardiomyopathy; 8.7% hypertrophic cardiomyopathy; 8.7% hypertensive cardiomyopathy. Fifty five percent of the patients were in group I and the major aetiology were coronary artery disease and valvular heart disease; 25% of the patients were in group II and the major aetiology were coronary artery disease and hypertrophic cardiomyopathy; 20% of the patients were in group III, all had valvular heart disease. The global mortality during the hospitalisation period was 15.9%, mostly group III (29%) and II (17%).
Heart failure patients in NYHA class IV formed an heterogeneous group, requiring individualised therapeutic approaches. Left ventricular systolic dysfunction was the major pathophysiological mechanism, however, diastolic dysfunction and right ventricular dysfunction were frequent. Coronary artery disease presented as a frequent aetiology of heart failure, resulting in diastolic and/or systolic dysfunction. Valvular heart disease can be present as left ventricular systolic or diastolic dysfunction or as a right ventricular dysfunction, depending on the valvulopathy and the time of evolution. Echocardiography, in association with clinical features, has been very useful for each patient approach, allowing HF aetiology and pathophysiological mechanisms characterisation. The low mortality observed in this study was related certainly to the correction of precipitating factors, together with early etiologic diagnosis and pathophysiological characterisation, and adequate individualised treatment.
心力衰竭(HF)是一种取决于多种血流动力学和神经激素因素的动态临床综合征。该综合征不仅涉及左心室收缩功能障碍,还涉及左心室舒张功能障碍和右心室功能障碍。它们各自的临床特征和治疗方法有所不同。纽约心脏病协会(NYHA)IV级只是心力衰竭的多种预后因素之一;因此,严重心力衰竭并非NYHA IV级的同义词。
研究NYHA IV级的住院心力衰竭患者,以明确主要功能障碍的特征,并分析病情演变和死亡率。
对一项前瞻性研究进行回顾性分析。
108例住院患者(1985 - 1989年)。排除慢性阻塞性肺疾病和急性心肌梗死患者。
69例患者,29例女性和40例男性,年龄18至81岁(平均59±15.5岁)。
对患者进行临床检查,并进行胸部X线、心电图和M + 2D模式超声心动图检查。分为三组:第一组 - 以左心室收缩功能障碍为主的患者;第二组 - 以左心室舒张功能障碍为主的患者;第三组 - 以右心室功能障碍为主的患者。
41%的患者患有冠状动脉疾病;44%患有心脏瓣膜病;11.8%患有扩张型心肌病;8.7%患有肥厚型心肌病;8.7%患有高血压性心肌病。55%的患者属于第一组,主要病因是冠状动脉疾病和心脏瓣膜病;25%的患者属于第二组,主要病因是冠状动脉疾病和肥厚型心肌病;20%的患者属于第三组(均患有心脏瓣膜病)。住院期间的总死亡率为15.9%,主要是第三组(29%)和第二组(17%)。
NYHA IV级的心力衰竭患者构成一个异质性群体,需要个体化的治疗方法。左心室收缩功能障碍是主要的病理生理机制,然而,舒张功能障碍和右心室功能障碍也很常见。冠状动脉疾病是心力衰竭的常见病因,可导致舒张和/或收缩功能障碍。心脏瓣膜病可表现为左心室收缩或舒张功能障碍,或右心室功能障碍,这取决于瓣膜病变和病程。超声心动图结合临床特征,对每个患者的诊疗非常有用,有助于明确心力衰竭的病因和病理生理机制。本研究中观察到的低死亡率肯定与诱发因素的纠正、早期病因诊断和病理生理特征分析以及适当的个体化治疗有关。